Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...

Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...

Phase 3 data from KOASTAL-1 study of navacaprant in MDD expected around the end of 2024; KOASTAL-2 and KOASTAL-3 topline data expected in the ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

Discover how metabolic ketogenic therapy differs from the popular diet trend and its potential benefits for bipolar disorder.

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Figuring out a mental health disorder can be a challenge, as many symptoms are shared by the various diagnoses. Depression, ...

Your dementia treatment plan will depend on underlying causes and how advanced your condition is. Not everyone needs significant lifestyle changes or medication, particularly in early stage dement ...

The best way to determine if you have bipolar 1 or bipolar 2 is to speak with a psychiatrist or licensed mental health professional. Understanding which type of the disorder you have can help you live ...